(19)
(11) EP 2 257 543 A1

(12)

(43) Date of publication:
08.12.2010 Bulletin 2010/49

(21) Application number: 09715794.5

(22) Date of filing: 27.02.2009
(51) International Patent Classification (IPC): 
C07D 401/14(2006.01)
A61K 31/536(2006.01)
A61P 25/28(2006.01)
 A61K 31/517(2006.01)
A61P 25/04(2006.01)
C07D 413/14(2006.01)
(86) International application number:
PCT/SE2009/050216
(87) International publication number:
WO 2009/108117 (03.09.2009 Gazette 2009/36)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA RS

(30) Priority: 28.02.2008 US 32138

(71) Applicant: AstraZeneca AB
151 85 Södertälje (SE)

(72) Inventors:
  • CHENG, Yun-Xing
    Montreal, Québec H4S 1Z9 (CA)
  • LUO, Xuehong
    Montreal, Québec H4S 1Z9 (CA)
  • POURASHRAF, Mehrnaz
    Montreal, Québec H4S 1Z9 (CA)
  • SANTHAKUMAR, Vijayaratnam
    Montreal, Québec H4S 1Z9 (CA)
  • TOMASZEWSKI, Miroslaw Jerzy
    Montreal, Québec H4S 1Z9 (CA)

   


(54) MUSCARINIC RECEPTOR AGONISTS, COMPOSITIONS, METHODS OF TREATMENT THEREOF, AND PROCESSES FOR PREPARATION THEREOF 177